Melanie Poulin-Costello

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

Tim Eisen, T. Ahmad, Keith T. Flaherty et al. · British Journal of Cancer · 2006 · 636 citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC)

Josep M. Llovet, Serafino Ricci, Vincenzo Mazzaferro et al. · Journal of Clinical Oncology · 2007 · 233 citations

Medicine, Oncology, Pharmacology +13

Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population

Kim Papp, Yves Poulin, Robert Bissonnette et al. · Journal of the American Academy of Dermatology · 2010 · 100 citations

Medicine, Dermatology, Pharmacotherapy +4

Etiology of community-acquired pneumonia treated in an ambulatory setting

Thomas J. Marrie, Melanie Poulin-Costello, Michael D. Beecroft et al. · Respiratory Medicine · 2004 · 71 citations

Medicine, Community Medicine, Infectious Diseases +13

The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis

Janet Pope, Boulos Haraoui, Carter Thorne et al. · Annals of the Rheumatic Diseases · 2013 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14